CN104001057A - Medicine for treating heart and kidney imbalanced schizophrenia and preparing method thereof - Google Patents
Medicine for treating heart and kidney imbalanced schizophrenia and preparing method thereof Download PDFInfo
- Publication number
- CN104001057A CN104001057A CN201410258697.2A CN201410258697A CN104001057A CN 104001057 A CN104001057 A CN 104001057A CN 201410258697 A CN201410258697 A CN 201410258697A CN 104001057 A CN104001057 A CN 104001057A
- Authority
- CN
- China
- Prior art keywords
- weight portions
- radix
- weight
- medicine
- weight portion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 111
- 210000002216 heart Anatomy 0.000 title claims abstract description 70
- 238000000034 method Methods 0.000 title claims abstract description 21
- 210000003734 kidney Anatomy 0.000 title abstract description 44
- 201000000980 schizophrenia Diseases 0.000 title abstract description 23
- 229940079593 drug Drugs 0.000 title description 10
- 241000628997 Flos Species 0.000 claims abstract description 41
- 229920002472 Starch Polymers 0.000 claims abstract description 20
- 241001116389 Aloe Species 0.000 claims abstract description 16
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 16
- 239000012567 medical material Substances 0.000 claims abstract description 6
- 239000008107 starch Substances 0.000 claims abstract description 6
- 235000019698 starch Nutrition 0.000 claims abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 132
- 238000011282 treatment Methods 0.000 claims description 88
- 239000000463 material Substances 0.000 claims description 54
- 239000000243 solution Substances 0.000 claims description 43
- 239000013521 mastic Substances 0.000 claims description 40
- 210000000582 semen Anatomy 0.000 claims description 38
- 239000000284 extract Substances 0.000 claims description 33
- 239000000843 powder Substances 0.000 claims description 30
- 208000017169 kidney disease Diseases 0.000 claims description 26
- 201000006370 kidney failure Diseases 0.000 claims description 26
- 238000002360 preparation method Methods 0.000 claims description 24
- 241000237636 Pheretima Species 0.000 claims description 22
- 239000000203 mixture Substances 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 239000011021 lapis lazuli Substances 0.000 claims description 20
- 238000010992 reflux Methods 0.000 claims description 20
- 241000255791 Bombyx Species 0.000 claims description 18
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 claims description 18
- 235000001892 vitamin D2 Nutrition 0.000 claims description 18
- 239000011653 vitamin D2 Substances 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 16
- 239000008517 radix Trichosanthis Substances 0.000 claims description 16
- 235000012239 silicon dioxide Nutrition 0.000 claims description 16
- 210000001113 umbilicus Anatomy 0.000 claims description 15
- 235000019890 Amylum Nutrition 0.000 claims description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 13
- 238000001914 filtration Methods 0.000 claims description 13
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 12
- 235000021355 Stearic acid Nutrition 0.000 claims description 12
- 239000012153 distilled water Substances 0.000 claims description 12
- 239000002552 dosage form Substances 0.000 claims description 12
- 239000008187 granular material Substances 0.000 claims description 12
- 238000010438 heat treatment Methods 0.000 claims description 12
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 12
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 12
- 238000012545 processing Methods 0.000 claims description 12
- 238000011084 recovery Methods 0.000 claims description 12
- 230000002829 reductive effect Effects 0.000 claims description 12
- 239000008117 stearic acid Substances 0.000 claims description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 8
- 229930006000 Sucrose Natural products 0.000 claims description 8
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 8
- 229910052799 carbon Inorganic materials 0.000 claims description 8
- 239000006071 cream Substances 0.000 claims description 8
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 8
- 239000006187 pill Substances 0.000 claims description 8
- 238000004321 preservation Methods 0.000 claims description 8
- 239000000047 product Substances 0.000 claims description 8
- 239000011265 semifinished product Substances 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 238000004659 sterilization and disinfection Methods 0.000 claims description 8
- 239000000758 substrate Substances 0.000 claims description 8
- 229960004793 sucrose Drugs 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 4
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 4
- 150000001298 alcohols Chemical class 0.000 claims description 4
- 238000003113 dilution method Methods 0.000 claims description 4
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 claims description 4
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims description 4
- 239000004744 fabric Substances 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 239000008101 lactose Substances 0.000 claims description 4
- 235000019359 magnesium stearate Nutrition 0.000 claims description 4
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 4
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 4
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 4
- GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 claims description 4
- 238000001556 precipitation Methods 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 47
- 230000001225 therapeutic effect Effects 0.000 abstract description 11
- 230000008901 benefit Effects 0.000 abstract description 7
- 235000011389 fruit/vegetable juice Nutrition 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 240000000249 Morus alba Species 0.000 abstract description 2
- 235000008708 Morus alba Nutrition 0.000 abstract description 2
- 235000017166 Bambusa arundinacea Nutrition 0.000 abstract 2
- 235000017491 Bambusa tulda Nutrition 0.000 abstract 2
- 244000082204 Phyllostachys viridis Species 0.000 abstract 2
- 235000015334 Phyllostachys viridis Nutrition 0.000 abstract 2
- 241001080798 Polygala tenuifolia Species 0.000 abstract 2
- 239000011425 bamboo Substances 0.000 abstract 2
- 244000001632 Acorus gramineus Species 0.000 abstract 1
- 235000013073 Acorus gramineus Nutrition 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 244000248539 Asparagus cochinchinensis Species 0.000 abstract 1
- 235000009292 Asparagus cochinchinensis Nutrition 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 241000255789 Bombyx mori Species 0.000 abstract 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 abstract 1
- 241000037740 Coptis chinensis Species 0.000 abstract 1
- 244000111489 Gardenia augusta Species 0.000 abstract 1
- 235000018958 Gardenia augusta Nutrition 0.000 abstract 1
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 241000234435 Lilium Species 0.000 abstract 1
- 241000243684 Lumbricus Species 0.000 abstract 1
- 240000002853 Nelumbo nucifera Species 0.000 abstract 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 244000233952 Polygonum bistorta Species 0.000 abstract 1
- 235000014258 Polygonum bistorta Nutrition 0.000 abstract 1
- 235000011158 Prunus mume Nutrition 0.000 abstract 1
- 244000018795 Prunus mume Species 0.000 abstract 1
- 241000923606 Schistes Species 0.000 abstract 1
- 241000270708 Testudinidae Species 0.000 abstract 1
- 241000218989 Trichosanthes Species 0.000 abstract 1
- 244000126014 Valeriana officinalis Species 0.000 abstract 1
- 235000013832 Valeriana officinalis Nutrition 0.000 abstract 1
- 244000089698 Zanthoxylum simulans Species 0.000 abstract 1
- 229910001919 chlorite Inorganic materials 0.000 abstract 1
- 229910052619 chlorite group Inorganic materials 0.000 abstract 1
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical compound OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 abstract 1
- 235000017803 cinnamon Nutrition 0.000 abstract 1
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 229910052602 gypsum Inorganic materials 0.000 abstract 1
- 239000010440 gypsum Substances 0.000 abstract 1
- 235000016788 valerian Nutrition 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 68
- 239000008280 blood Substances 0.000 description 68
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 47
- 201000010099 disease Diseases 0.000 description 44
- 210000004185 liver Anatomy 0.000 description 41
- 210000002784 stomach Anatomy 0.000 description 38
- 235000009508 confectionery Nutrition 0.000 description 33
- 206010062717 Increased upper airway secretion Diseases 0.000 description 31
- 208000026435 phlegm Diseases 0.000 description 31
- 208000002193 Pain Diseases 0.000 description 30
- 230000036407 pain Effects 0.000 description 30
- 210000004072 lung Anatomy 0.000 description 27
- 230000007812 deficiency Effects 0.000 description 26
- 210000000952 spleen Anatomy 0.000 description 23
- 230000001717 pathogenic effect Effects 0.000 description 22
- 208000024891 symptom Diseases 0.000 description 22
- 206010010904 Convulsion Diseases 0.000 description 21
- 230000001737 promoting effect Effects 0.000 description 21
- 230000036461 convulsion Effects 0.000 description 20
- 206010047700 Vomiting Diseases 0.000 description 19
- 230000006870 function Effects 0.000 description 19
- 239000002398 materia medica Substances 0.000 description 18
- 238000012360 testing method Methods 0.000 description 18
- 230000035922 thirst Effects 0.000 description 18
- 230000008673 vomiting Effects 0.000 description 18
- 206010011224 Cough Diseases 0.000 description 17
- 241001465754 Metazoa Species 0.000 description 17
- 239000003172 expectorant agent Substances 0.000 description 16
- 230000003419 expectorant effect Effects 0.000 description 16
- 208000001848 dysentery Diseases 0.000 description 13
- 208000006820 Arthralgia Diseases 0.000 description 12
- 206010015037 epilepsy Diseases 0.000 description 12
- 210000003205 muscle Anatomy 0.000 description 12
- 244000052769 pathogen Species 0.000 description 12
- 231100000614 poison Toxicity 0.000 description 12
- 206010010774 Constipation Diseases 0.000 description 11
- 206010003549 asthenia Diseases 0.000 description 11
- 230000017531 blood circulation Effects 0.000 description 11
- 206010012735 Diarrhoea Diseases 0.000 description 10
- 206010033557 Palpitations Diseases 0.000 description 10
- 206010037660 Pyrexia Diseases 0.000 description 10
- 230000008961 swelling Effects 0.000 description 10
- 206010007247 Carbuncle Diseases 0.000 description 9
- 208000032843 Hemorrhage Diseases 0.000 description 9
- 241000699670 Mus sp. Species 0.000 description 9
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 9
- 210000001124 body fluid Anatomy 0.000 description 9
- 239000010839 body fluid Substances 0.000 description 9
- 210000000988 bone and bone Anatomy 0.000 description 9
- 230000004438 eyesight Effects 0.000 description 9
- 206010022437 insomnia Diseases 0.000 description 9
- 201000007227 lymph node tuberculosis Diseases 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 210000005036 nerve Anatomy 0.000 description 9
- 238000010791 quenching Methods 0.000 description 9
- 230000001105 regulatory effect Effects 0.000 description 9
- 206010000087 Abdominal pain upper Diseases 0.000 description 8
- 208000001431 Psychomotor Agitation Diseases 0.000 description 8
- 208000028017 Psychotic disease Diseases 0.000 description 8
- 206010038743 Restlessness Diseases 0.000 description 8
- 230000001149 cognitive effect Effects 0.000 description 8
- 230000007547 defect Effects 0.000 description 8
- 230000008451 emotion Effects 0.000 description 8
- 230000003203 everyday effect Effects 0.000 description 8
- 239000003440 toxic substance Substances 0.000 description 8
- 238000010792 warming Methods 0.000 description 8
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 7
- 208000005392 Spasm Diseases 0.000 description 7
- 238000010171 animal model Methods 0.000 description 7
- 230000006399 behavior Effects 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 238000003304 gavage Methods 0.000 description 7
- 230000023597 hemostasis Effects 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 231100000252 nontoxic Toxicity 0.000 description 7
- 230000003000 nontoxic effect Effects 0.000 description 7
- 208000011580 syndromic disease Diseases 0.000 description 7
- 235000019640 taste Nutrition 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 7
- 201000004624 Dermatitis Diseases 0.000 description 6
- 208000004547 Hallucinations Diseases 0.000 description 6
- 206010019233 Headaches Diseases 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 6
- 208000003251 Pruritus Diseases 0.000 description 6
- 206010040880 Skin irritation Diseases 0.000 description 6
- 241000191967 Staphylococcus aureus Species 0.000 description 6
- 208000033809 Suppuration Diseases 0.000 description 6
- 208000031971 Yin Deficiency Diseases 0.000 description 6
- 210000001015 abdomen Anatomy 0.000 description 6
- 230000001154 acute effect Effects 0.000 description 6
- 230000001186 cumulative effect Effects 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 231100000869 headache Toxicity 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- 210000000936 intestine Anatomy 0.000 description 6
- 239000002574 poison Substances 0.000 description 6
- 231100000475 skin irritation Toxicity 0.000 description 6
- 230000036556 skin irritation Effects 0.000 description 6
- 230000007958 sleep Effects 0.000 description 6
- 208000004371 toothache Diseases 0.000 description 6
- 210000001835 viscera Anatomy 0.000 description 6
- 208000004998 Abdominal Pain Diseases 0.000 description 5
- 206010010071 Coma Diseases 0.000 description 5
- 206010012239 Delusion Diseases 0.000 description 5
- 208000008454 Hyperhidrosis Diseases 0.000 description 5
- 206010026749 Mania Diseases 0.000 description 5
- 206010068319 Oropharyngeal pain Diseases 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 206010043458 Thirst Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 208000006673 asthma Diseases 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 230000001914 calming effect Effects 0.000 description 5
- 210000000038 chest Anatomy 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 231100000868 delusion Toxicity 0.000 description 5
- 208000002173 dizziness Diseases 0.000 description 5
- 208000001780 epistaxis Diseases 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 210000000232 gallbladder Anatomy 0.000 description 5
- 210000003128 head Anatomy 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 241000411851 herbal medicine Species 0.000 description 5
- 208000021760 high fever Diseases 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 230000008506 pathogenesis Effects 0.000 description 5
- 230000021317 sensory perception Effects 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 239000003053 toxin Substances 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- 235000014101 wine Nutrition 0.000 description 5
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 208000007101 Muscle Cramp Diseases 0.000 description 4
- 206010036790 Productive cough Diseases 0.000 description 4
- 206010043376 Tetanus Diseases 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 208000002399 aphthous stomatitis Diseases 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 230000000740 bleeding effect Effects 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 230000002950 deficient Effects 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 208000014617 hemorrhoid Diseases 0.000 description 4
- 201000001881 impotence Diseases 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- 201000004792 malaria Diseases 0.000 description 4
- 235000013372 meat Nutrition 0.000 description 4
- 230000001617 migratory effect Effects 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 244000045947 parasite Species 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 230000000698 schizophrenic effect Effects 0.000 description 4
- 235000014347 soups Nutrition 0.000 description 4
- 210000003802 sputum Anatomy 0.000 description 4
- 208000024794 sputum Diseases 0.000 description 4
- 230000035900 sweating Effects 0.000 description 4
- 238000010998 test method Methods 0.000 description 4
- 231100000765 toxin Toxicity 0.000 description 4
- 206010000077 Abdominal mass Diseases 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010011878 Deafness Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 206010013954 Dysphoria Diseases 0.000 description 3
- 208000004232 Enteritis Diseases 0.000 description 3
- 201000000297 Erysipelas Diseases 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 208000015817 Infant Nutrition disease Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 208000019255 Menstrual disease Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 206010034702 Persecutory delusion Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 208000032023 Signs and Symptoms Diseases 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 206010042674 Swelling Diseases 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 230000003935 attention Effects 0.000 description 3
- 235000019658 bitter taste Nutrition 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 230000003177 cardiotonic effect Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 231100000895 deafness Toxicity 0.000 description 3
- 230000006735 deficit Effects 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 208000016354 hearing loss disease Diseases 0.000 description 3
- 210000003026 hypopharynx Anatomy 0.000 description 3
- 238000011337 individualized treatment Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000002147 killing effect Effects 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 230000000242 pagocytic effect Effects 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 230000004206 stomach function Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- 210000004291 uterus Anatomy 0.000 description 3
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- 206010050013 Abulia Diseases 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 206010002942 Apathy Diseases 0.000 description 2
- 206010002953 Aphonia Diseases 0.000 description 2
- 206010003591 Ataxia Diseases 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 206010010356 Congenital anomaly Diseases 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- 206010010947 Coordination abnormal Diseases 0.000 description 2
- 206010012289 Dementia Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 208000010228 Erectile Dysfunction Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 208000036119 Frailty Diseases 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 238000012449 Kunming mouse Methods 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 206010025421 Macule Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000007443 Neurasthenia Diseases 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- FYRHTIWFKXZWAD-UHFFFAOYSA-N Sarisan Chemical compound C1=C(CC=C)C(OC)=CC2=C1OCO2 FYRHTIWFKXZWAD-UHFFFAOYSA-N 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 206010039897 Sedation Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 208000024780 Urticaria Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- 208000031975 Yang Deficiency Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 231100000460 acute oral toxicity Toxicity 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000001773 anti-convulsant effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 230000010100 anticoagulation Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 206010008118 cerebral infarction Diseases 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 208000035850 clinical syndrome Diseases 0.000 description 2
- 208000010877 cognitive disease Diseases 0.000 description 2
- 230000003920 cognitive function Effects 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 208000028659 discharge Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 208000017574 dry cough Diseases 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 238000007667 floating Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 230000000147 hypnotic effect Effects 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 230000007954 hypoxia Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 208000016290 incoordination Diseases 0.000 description 2
- 208000021267 infertility disease Diseases 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 239000008518 lycium barbarum polysaccharide Substances 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 230000001932 seasonal effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000036280 sedation Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000004904 shortening Methods 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 231100000022 skin irritation / corrosion Toxicity 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 208000023409 throat pain Diseases 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- 231100000820 toxicity test Toxicity 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000008675 zhuhuang Substances 0.000 description 2
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- PMXMIIMHBWHSKN-UHFFFAOYSA-N 3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC=3C(=O)N4CCCC(O)C4=NC=3C)=NOC2=C1 PMXMIIMHBWHSKN-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000117 Abnormal behaviour Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 208000017194 Affective disease Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 235000010894 Artemisia argyi Nutrition 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 241000003910 Baronia <angiosperm> Species 0.000 description 1
- 208000003014 Bites and Stings Diseases 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000013017 Child Nutrition disease Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 241001550206 Colla Species 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 206010012241 Delusion of grandeur Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010012374 Depressed mood Diseases 0.000 description 1
- 206010051244 Dyschezia Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 206010016029 Face oedema Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010067715 Gastrointestinal sounds abnormal Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 208000018779 Globus Sensation Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019072 Hallucination, olfactory Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010049976 Impatience Diseases 0.000 description 1
- 206010021531 Impetigo Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241000699684 Meriones unguiculatus Species 0.000 description 1
- 241000361919 Metaphire sieboldi Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000019022 Mood disease Diseases 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 241000699667 Mus spretus Species 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 206010028916 Neologism Diseases 0.000 description 1
- 208000027626 Neurocognitive disease Diseases 0.000 description 1
- 206010029412 Nightmare Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241001092500 Photinia x fraseri Species 0.000 description 1
- 241000596297 Photis Species 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 208000037062 Polyps Diseases 0.000 description 1
- 208000037048 Prodromal Symptoms Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- 241000167686 Reichardia Species 0.000 description 1
- 206010062104 Renal mass Diseases 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 241000131808 Scolopendra Species 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- 206010061363 Skeletal injury Diseases 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 208000003217 Tetany Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 244000044283 Toxicodendron succedaneum Species 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000016571 aggressive behavior Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 201000009961 allergic asthma Diseases 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000000433 anti-nutritional effect Effects 0.000 description 1
- 230000002225 anti-radical effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 244000030166 artemisia Species 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 201000009361 ascariasis Diseases 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 1
- 229910001626 barium chloride Inorganic materials 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 235000019994 cava Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- QZUDBNBUXVUHMW-UHFFFAOYSA-N clozapine Chemical compound C1CN(C)CCN1C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12 QZUDBNBUXVUHMW-UHFFFAOYSA-N 0.000 description 1
- 229940068796 clozaril Drugs 0.000 description 1
- 229960001338 colchicine Drugs 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000007937 eating Effects 0.000 description 1
- 230000006397 emotional response Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005242 forging Methods 0.000 description 1
- 239000010135 fructus aurantii immaturus Substances 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000000025 haemostatic effect Effects 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000010365 information processing Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 210000001767 medulla oblongata Anatomy 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 208000010553 multiple abscesses Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000002981 neuropathic effect Effects 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 238000007034 nitrosation reaction Methods 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000001734 parasympathetic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000032361 posttranscriptional gene silencing Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 229940001470 psychoactive drug Drugs 0.000 description 1
- 239000004089 psychotropic agent Substances 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 208000010540 rapid respiration Diseases 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- RAPZEAPATHNIPO-UHFFFAOYSA-N risperidone Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC=3C(=O)N4CCCCC4=NC=3C)=NOC2=C1 RAPZEAPATHNIPO-UHFFFAOYSA-N 0.000 description 1
- 229960001534 risperidone Drugs 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 230000010332 selective attention Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 230000006403 short-term memory Effects 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 238000010911 splenectomy Methods 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 210000005182 tip of the tongue Anatomy 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 201000006382 tuberculoid leprosy Diseases 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000001755 vocal effect Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 230000003936 working memory Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Group | Number of cases | Recovery from illness | Effective | Effectively | Invalid | Recovery from illness and obvious effective rate | Effective percentage |
Treatment group 1 | 42 | 13 | 14 | 10 | 5 | (27)64.3% | 88.1% |
Treatment group 2 | 42 | 14 | 15 | 10 | 3 | (29)69.0% | 92.9% |
Treatment group 3 | 42 | 16 | 17 | 8 | 1 | (33)78.6% | 97.6% |
Matched group | 42 | 5 | 9 | 15 | 13 | (14)33.3% | 69.0% |
Group | Number of cases | 2-3 the course for the treatment of | 4-5 the course for the treatment of | The 6th course for the treatment of |
Treatment group 1 | 27 | 8(29.6%) | 11(40.7%) | 8(29.6%) |
Treatment group 2 | 29 | 9(31.0%) | 12(41.4%) | 8(27.6%) |
Treatment group 3 | 33 | 11(33.3%) | 15(45.6%) | 7(21.2%) |
Matched group | 14 | 3(21.4%) | 5(35.7%) | 6(42.9%) |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410258697.2A CN104001057B (en) | 2014-06-12 | 2014-06-12 | For treating the heart schizoid medicine of kidney disorder type and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410258697.2A CN104001057B (en) | 2014-06-12 | 2014-06-12 | For treating the heart schizoid medicine of kidney disorder type and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104001057A true CN104001057A (en) | 2014-08-27 |
CN104001057B CN104001057B (en) | 2016-07-13 |
Family
ID=51362145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410258697.2A Expired - Fee Related CN104001057B (en) | 2014-06-12 | 2014-06-12 | For treating the heart schizoid medicine of kidney disorder type and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104001057B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105535751A (en) * | 2016-01-15 | 2016-05-04 | 夏承生 | Traditional Chinese medicine for treating postdural puncture headache and preparation method thereof |
CN105561083A (en) * | 2016-01-13 | 2016-05-11 | 济南思拓新源医药科技有限公司 | Medicine composition for treating blood stasis heating type postpartum fever and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101816756A (en) * | 2010-06-02 | 2010-09-01 | 泰一和浦(北京)中医药研究院有限公司 | Chinese medicinal composition for treating upset and irritability and preparation method thereof |
CN101816771A (en) * | 2010-06-02 | 2010-09-01 | 泰一和浦(北京)中医药研究院有限公司 | Chinese medicinal composition for treating epilepsy disease and preparation method thereof |
CN102886013A (en) * | 2012-10-26 | 2013-01-23 | 王澜舸 | Shiniu antipyretic oral liquid |
-
2014
- 2014-06-12 CN CN201410258697.2A patent/CN104001057B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101816756A (en) * | 2010-06-02 | 2010-09-01 | 泰一和浦(北京)中医药研究院有限公司 | Chinese medicinal composition for treating upset and irritability and preparation method thereof |
CN101816771A (en) * | 2010-06-02 | 2010-09-01 | 泰一和浦(北京)中医药研究院有限公司 | Chinese medicinal composition for treating epilepsy disease and preparation method thereof |
CN102886013A (en) * | 2012-10-26 | 2013-01-23 | 王澜舸 | Shiniu antipyretic oral liquid |
Non-Patent Citations (4)
Title |
---|
廖声俊: "癫狂治验摘介(一)", 《新中医》 * |
李建国等: "中医药对抑郁症单胺类神经递质影响的研究进展", 《贵阳中医学院学报》 * |
赵杰: "滋阴清热治疗儿童神经系统疾病验案举隅", 《山西中医》 * |
陈永灿: "育阴开郁治不寐", 《江苏中医药》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105561083A (en) * | 2016-01-13 | 2016-05-11 | 济南思拓新源医药科技有限公司 | Medicine composition for treating blood stasis heating type postpartum fever and preparation method thereof |
CN105535751A (en) * | 2016-01-15 | 2016-05-04 | 夏承生 | Traditional Chinese medicine for treating postdural puncture headache and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN104001057B (en) | 2016-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101804166B (en) | Traditional Chinese medicine composition for treating dermatitis and eczema of infants | |
CN103520572B (en) | A kind of Chinese medicine composition being used for the treatment of atopic dermatitis and preparation method thereof | |
CN103432475B (en) | Traditional Chinese medicine composition for treating allergic rhinitis and preparation method thereof | |
CN102178804B (en) | Chinese medicinal composition for treating perianal eczema and preparation method thereof | |
CN104398934A (en) | Traditional Chinese medicine combination for treating cutaneous pruritus and preparation method thereof | |
CN103638250B (en) | One treats prosopoplegic Chinese medicine preparation and preparation method thereof | |
CN104288609A (en) | Traditional Chinese medicine composition curing stomach fire flaming gingivitis and preparation method for traditional Chinese medicine composition | |
CN103860941A (en) | Traditional Chinese medicine for treating schizophrenia and preparation method thereof | |
CN102178877B (en) | External preparation for treating eczema of scrotum and preparation method thereof | |
CN102000164B (en) | Traditional Chinese medicine composition for treating psoriasis and preparation method thereof | |
CN104857288B (en) | Treat the Chinese medicine preparation and preparation method thereof of white hair | |
CN104127813A (en) | Traditional Chinese medicinal composition for curing qi-blood deficiency type bedsore and preparation method thereof | |
CN103239662A (en) | Parasite expelling Chinese herbal preparation for animals | |
CN102908474B (en) | Medicinal liquor for treating neurosis | |
CN104147538A (en) | Traditional Chinese medicine preparation for treating diabetes foot in dampness-heat toxin-abundant type and preparation method thereof | |
CN104001057B (en) | For treating the heart schizoid medicine of kidney disorder type and preparation method thereof | |
CN104524464A (en) | Traditional Chinese medicine preparation for treating hyperactivity and preparation method of traditional Chinese medicine preparation | |
CN103920042A (en) | Drug for treating heat invasion nutritive blood type virus meningitis, as well as preparation method thereof | |
CN104474523A (en) | Medicine for treating phlegm-heat accumulated-in-lung type mycoplasma pneumonia and preparation method thereof | |
CN104013950A (en) | Traditional Chinese medicine composition for treating toxin and decay type bedsore and preparation method of composition | |
CN106880758A (en) | It is a kind of for pruritus vulvue and the Chinese medicine preparation and preparation method of eczema stubborn dermatitis | |
CN106138913A (en) | A kind of pharmaceutical composition treating cerebral thrombosis and preparation method thereof | |
CN106177736A (en) | A kind of alleviate gastrointestinal upset Chinese mugwort leaf health care tea causing constipation and preparation method thereof | |
CN105232657A (en) | Traditional Chinese medicine for treating syringomyelia | |
CN103948904A (en) | Medicine for treating wind-phlegm stasis type vertiginous epilepsy and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Liu Guangyi Inventor after: Cao Yongxian Inventor after: Zhang Nana Inventor before: Liu Guangyi |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LIU GUANGYI TO: LIU GUANGYI CAO YONGXIAN ZHANG NANA |
|
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Hui Inventor after: Liu Guangyi Inventor after: Zhang Di Inventor after: Cao Yongxian Inventor after: Zhang Nana Inventor after: Liu Bing Inventor before: Liu Guangyi Inventor before: Cao Yongxian Inventor before: Zhang Nana |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160422 Address after: 266003 Jiangsu Road, Shandong, China, No. 16, No. Applicant after: Affiliated Hospital of University Of Qingdao Applicant after: Qiingdao University hospital Address before: 266003 Jiangsu Road, Shandong, China, No. 16, No. Applicant before: Affiliated Hospital of University Of Qingdao |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160713 Termination date: 20170612 |